Olawade, David ORCID: https://orcid.org/0000-0003-0188-9836, Kade, Ayomikun, Egbon, Eghosasere, Usman, Sunday Oluwadamilola, Fapohunda, Oluwaseun, Ijiwade, James and Ogbonna, Covenant Ebubechi (2025) Bioinformatics and artificial intelligence in genomic data analysis: current advances and future directions. Molecular genetics and genomics : MGG, 300 (1). p. 111.

Full text not available from this repository.

Abstract

The exponential growth of genomic data from next-generation sequencing technologies has created an urgent need for advanced computational approaches that can efficiently process, integrate, and interpret complex multi-dimensional biological information. This comprehensive review examines how artificial intelligence (AI), particularly machine learning and deep learning, is transforming genomic data analysis and addressing critical limitations of traditional bioinformatics methods. A thorough literature search was conducted across PubMed, Scopus, and Google Scholar databases, targeting peer-reviewed studies published between 2010 and 2024. This review addresses a critical knowledge gap by synthesizing current AI applications across the genomic analysis pipeline, from variant calling to multi-omics integration and personalized medicine, whilst critically evaluating emerging technologies including explainable AI and federated learning. AI methods have significantly improved accuracy in variant calling, gene expression profiling, and disease risk prediction. Key findings demonstrate that deep learning models achieve superior performance in complex pattern recognition, whilst explainable AI addresses the "black box" problem essential for clinical adoption. Federated learning enables privacy-preserving collaborative research across institutions. However, significant challenges remain, including data standardization, computational costs, algorithm interpretability, and ethical considerations surrounding privacy and algorithmic bias. Future directions include quantum computing integration and AI-enhanced CRISPR technologies. This review concludes that whilst AI represents a transformative force in genomic research, successful clinical translation requires addressing current technical and ethical challenges through interdisciplinary collaboration, robust validation frameworks, and responsible implementation strategies prioritizing patient safety and data security. [Abstract copyright: © 2025. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.]

Item Type:	Article
Status:	Published
DOI:	10.1007/s00438-025-02314-x
School/Department:	London Campus
URI:	https://ray.yorksj.ac.uk/id/eprint/13679

University Staff: Request a correction | RaY Editors: Update this record